CCR3 CRISPR Knockout Jurkat Cell Line – T2 AJ240

The CCR3 CRISPR Knockout Jurkat Cell Line is a specialized derivative of the Jurkat T lymphocyte cell line, engineered via CRISPR/Cas9 technology to lack the CCR3 gene, which encodes the chemokine receptor 3. This modification facilitates the study of CCR3’s roles in immune cell dynamics, particularly in T cell behavior and inflammatory responses. By analyzing how the absence of CCR3 affects T cell migration, activation, and response to chemokine signals, researchers can gain insights into its involvement in immunological disorders and potential therapeutic avenues for conditions such as asthma and allergies. This cell line serves as an invaluable tool for in-depth immunological research and the development of targeted treatments.